EMA Guidance for medicine developers and companies on COVID-19
The European Medicines Agency (EMA) released a guidance for medicine developers and pharmaceutical companies to help speed up medicine and vaccine development and approval for COVID-19, and on how they should address the regulatory challenges arising from the COVID-19 pandemic. The overall aim is to accelerate and simplify the procedures for the development of COVID-19 [...]